| scholarly article | Q13442814 |
| P2093 | author name string | Kenneth D R Setchell | |
| Xueheng Zhao | |||
| James E Heubi | |||
| Eileen C King | |||
| Nadine M Brown | |||
| Mark J Messina | |||
| Stephanie L Lindley | |||
| P2860 | cites work | Equol: pharmacokinetics and biological actions | Q24594626 |
| Soy food intake and breast cancer survival | Q24609611 | ||
| The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers | Q24653795 | ||
| Method of defining equol-producer status and its frequency among vegetarians | Q28253168 | ||
| Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta | Q28283637 | ||
| Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice | Q46884616 | ||
| Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. | Q51810532 | ||
| The health implications of soy infant formula. | Q51937060 | ||
| Soybeans inhibit mammary tumors in models of breast cancer | Q68567028 | ||
| Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats | Q73087939 | ||
| Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes | Q73209056 | ||
| Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry | Q73462668 | ||
| Exposure of infants to phyto-oestrogens from soy-based infant formula | Q73499013 | ||
| Phyto-oestrogens in soy-based infant formula | Q73699617 | ||
| Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements | Q73707852 | ||
| Urinary pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein | Q73742435 | ||
| Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice | Q73924390 | ||
| HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids | Q74279576 | ||
| Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations | Q74453434 | ||
| Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability | Q74529751 | ||
| Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans | Q74535186 | ||
| Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice | Q77123340 | ||
| Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo | Q77220395 | ||
| Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men | Q77386775 | ||
| Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life | Q77665033 | ||
| Isoflavones in human breast milk and other biological fluids | Q77665039 | ||
| Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk | Q81332096 | ||
| Perspectives on the soy-breast cancer relation | Q83596916 | ||
| Phytoestrogens and breast cancer: a complex story | Q28295155 | ||
| Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations | Q28302033 | ||
| Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: a pilot randomized, placebo-controlled trial | Q28303727 | ||
| Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo | Q30438048 | ||
| Breast cancer risk with postmenopausal hormonal treatment | Q33223014 | ||
| Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials | Q33516196 | ||
| Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials | Q33590487 | ||
| Phytoestrogens: the "natural" selective estrogen receptor modulators? | Q33700680 | ||
| Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis | Q34115114 | ||
| Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease | Q34258149 | ||
| Is soy consumption good or bad for the breast? | Q34308323 | ||
| Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy | Q34334503 | ||
| Soy isoflavones--benefits and risks from nature's selective estrogen receptor modulators (SERMs). | Q34402868 | ||
| S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora | Q34417374 | ||
| The health consequences of early soy consumption | Q34553043 | ||
| Equol improves menopausal symptoms in Japanese women | Q34619714 | ||
| Epidemiology of soy exposures and breast cancer risk | Q34734223 | ||
| Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis | Q34943276 | ||
| The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women | Q35004789 | ||
| Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study | Q36315926 | ||
| Phytoestrogens and cardiovascular disease | Q36507677 | ||
| Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices | Q36668720 | ||
| Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary | Q36744585 | ||
| Selective estrogen receptor modulators and phytoestrogens | Q36984515 | ||
| Glucuronidation of the soyabean isoflavones genistein and daidzein by human liver is related to levels of UGT1A1 and UGT1A9 activity and alters isoflavone response in the MCF-7 human breast cancer cell line | Q39989392 | ||
| Dietary estrogens--a probable cause of infertility and liver disease in captive cheetahs | Q41318795 | ||
| Genotoxicity assessment of S-equol in bacterial mutation, chromosomal aberration, and rodent bone marrow micronucleus tests | Q42874928 | ||
| Soy food consumption and breast cancer prognosis | Q43569297 | ||
| Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones | Q43606362 | ||
| Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens | Q43622091 | ||
| Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. | Q43973983 | ||
| Solvent extraction selection in the determination of isoflavones in soy foods | Q44148630 | ||
| Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology. | Q44425874 | ||
| Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling | Q44488707 | ||
| Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor β-agonist being developed for the treatment of menopausal symptoms | Q44866925 | ||
| Soy processing influences growth of estrogen-dependent breast cancer tumors | Q44886527 | ||
| Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia | Q44961760 | ||
| Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice | Q46773787 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 1284-1294 | |
| P577 | publication date | 2011-09-28 | |
| P1433 | published in | American Journal of Clinical Nutrition | Q7713500 |
| P1476 | title | Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk | |
| P478 | volume | 94 |
| Q34125778 | A hypothesis regarding the molecular mechanism underlying dietary soy-induced effects on seizure propensity |
| Q30888332 | An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept |
| Q36472059 | Anti-proliferative effect of Flos Albiziae flavonoids on the human gastric cancer SGC-7901 cell line |
| Q38032972 | Can breast cancer patients use soyafoods to help reduce risk of CHD? |
| Q92317532 | Consumption of a soy drink has no effect on cognitive function but may alleviate vasomotor symptoms in post-menopausal women; a randomised trial |
| Q39169173 | Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2. |
| Q30736359 | Designing a broad-spectrum integrative approach for cancer prevention and treatment. |
| Q37307326 | Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults |
| Q41195274 | Effect of Soy Isoflavones on Growth of Representative Bacterial Species from the Human Gut. |
| Q34635316 | Effect of soy isoflavones on the growth of human breast tumors: findings from preclinical studies |
| Q47670578 | Equol Enhances Apoptosis-inducing Activity of Genistein by Increasing Bax/Bcl-xL Expression Ratio in MCF-7 Human Breast Cancer Cells |
| Q29248888 | Equol, a Dietary Daidzein Gut Metabolite Attenuates Microglial Activation and Potentiates Neuroprotection In Vitro |
| Q38609844 | Health impact of childhood and adolescent soy consumption |
| Q53264621 | Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant. |
| Q39034204 | Low dietary soy isoflavonoids increase hippocampal spine synapse density in ovariectomized rats |
| Q26861193 | Modification in the diet can induce beneficial effects against breast cancer |
| Q44816736 | Nutrikinetic modeling reveals order of genistein phase II metabolites appearance in human plasma |
| Q46601560 | Phase II metabolism of the soy isoflavones genistein and daidzein in humans, rats and mice: a cross-species and sex comparison |
| Q41680668 | Plasma bioavailability and changes in PBMC gene expression after treatment of ovariectomized rats with a commercial soy supplement. |
| Q36088558 | Potential Effects of Phytoestrogen Genistein in Modulating Acute Methotrexate Chemotherapy-Induced Osteoclastogenesis and Bone Damage in Rats. |
| Q37214757 | Rapid magnetic solid-phase extraction for the selective determination of isoflavones in soymilk using baicalin-functionalized magnetic nanoparticles |
| Q38000980 | Regulation of the immune response by soybean isoflavones |
| Q47157326 | Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones |
| Q92257455 | Rodent Models Assessing Mammary Tumor Prevention by Soy or Soy Isoflavones |
| Q28071946 | Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature |
| Q58697667 | Soy supplementation: Impact on gene expression in different tissues of ovariectomized rats and evaluation of the rat model to predict (post)menopausal health effect |
| Q47230001 | Soy, Soy Foods and Their Role in Vegetarian Diets |
| Q30835235 | Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons |
| Q26751544 | Soy-based renoprotection |
| Q34187693 | The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy |
| Q26824437 | The estrogenic content of rodent diets, bedding, cages, and water bottles and its effect on bisphenol A studies |
| Q41480570 | Transcriptional regulation of glutamic acid decarboxylase in the male mouse amygdala by dietary phyto-oestrogens |
| Q36282389 | Update on genistein and thyroid: an overall message of safety |
| Q89575330 | Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S-Equol and Its Consequences for ERα Activation |
| Q56672310 | Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk |
Search more.